/
Biological products, (no diagnostic substances) company · DE · FY ends Dec · Revenue $2M · -5649.21% margin · -$102M FCF
The business is unprofitable at the operating level (-5306.04% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Negative free cash flow of -$106M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$2M
Net Income (TTM)
-$98M
▲ +72.5% YoY
Op. Margin
-5649.21%
ROIC
-185.05%
▲ +159.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$102M
▼ -6.3% YoY
Op. Cash Flow (TTM)
-$102M
▼ -7.1% YoY
Net Debt
$17M
Cash & Equiv.
$49M
Continue Research